ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
3,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
6,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
7,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
8,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
8,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
8,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
8,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
10,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
10,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
10,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
10,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
11,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
12,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
13,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
15,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
15,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
15,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
15,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,6,Salivary gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
16,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
17,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
18,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
19,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
20,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
20,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
21,1,Arterial occlusive disease,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
21,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
22,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
22,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
22,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
23,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
24,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
25,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
25,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
25,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
26,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
27,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,1,Neurosis,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
29,1,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
30,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
33,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
34,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
34,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
34,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
35,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
36,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
37,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
38,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
38,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
38,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
38,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
38,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
38,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
38,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
39,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
40,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
40,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
41,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
41,2,Anal skin tags,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
41,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
41,4,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
42,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
42,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
42,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
43,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
43,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
44,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
44,2,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
44,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
45,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
45,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
47,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
48,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
48,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
49,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
50,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
50,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
51,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
53,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
53,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
53,3,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
53,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
53,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
53,6,Reticulocytopenia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
53,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
54,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
54,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
55,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
56,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
57,1,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
58,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
59,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
60,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
61,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
61,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
61,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
62,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
62,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
63,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
63,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
64,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
64,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
64,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
64,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
64,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
64,7,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
65,1,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
66,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
66,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
66,3,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
67,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
67,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
68,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
68,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
68,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
68,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
68,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
69,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
69,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
69,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,5,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
70,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,2,Enzyme level increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
70,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
71,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
72,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
73,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
74,1,Choluria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
74,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
74,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
74,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
74,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
75,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
76,1,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
76,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
76,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
76,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
77,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
77,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
77,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
77,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
77,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
77,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
77,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
77,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
78,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
78,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
79,1,Foetal anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
79,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
79,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
80,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
81,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
81,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
81,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
82,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
83,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
84,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
85,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
85,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
85,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
85,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
85,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
86,1,Allergic cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
86,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
86,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
86,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
87,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
87,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
89,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
89,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
90,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
91,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
91,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
91,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
91,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
93,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
93,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
93,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
93,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
93,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
93,6,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
93,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
94,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
95,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
96,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
96,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
97,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
97,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
98,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
100,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
101,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
101,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
101,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
102,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
102,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
104,1,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
104,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
104,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
105,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
105,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
